These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32131492)

  • 1. Non-Thermal Plasma Induces Antileukemic Effect Through mTOR Ubiquitination.
    Kim SY; Kim HJ; Kim HJ; Kim CH
    Cells; 2020 Mar; 9(3):. PubMed ID: 32131492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-thermal plasma induces AKT degradation through turn-on the MUL1 E3 ligase in head and neck cancer.
    Kim SY; Kim HJ; Kang SU; Kim YE; Park JK; Shin YS; Kim YS; Lee K; Kim CH
    Oncotarget; 2015 Oct; 6(32):33382-96. PubMed ID: 26450902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer.
    Kim SY; Kim HJ; Kim HJ; Kim DH; Han JH; Byeon HK; Lee K; Kim CH
    Autophagy; 2018; 14(3):385-403. PubMed ID: 29260979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
    Matsuzawa Y; Oshima S; Takahara M; Maeyashiki C; Nemoto Y; Kobayashi M; Nibe Y; Nozaki K; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Ma A; Watanabe M
    Autophagy; 2015; 11(7):1052-62. PubMed ID: 26043155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diosgenin induces ROS-dependent autophagy and cytotoxicity via mTOR signaling pathway in chronic myeloid leukemia cells.
    Jiang S; Fan J; Wang Q; Ju D; Feng M; Li J; Guan ZB; An D; Wang X; Ye L
    Phytomedicine; 2016 Mar; 23(3):243-52. PubMed ID: 26969378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation.
    Zhi X; Zhao D; Wang Z; Zhou Z; Wang C; Chen W; Liu R; Chen C
    Cancer Res; 2013 Jan; 73(1):385-94. PubMed ID: 23026136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coptisine induces autophagic cell death through down-regulation of PI3K/Akt/mTOR signaling pathway and up-regulation of ROS-mediated mitochondrial dysfunction in hepatocellular carcinoma Hep3B cells.
    Kim SY; Hwangbo H; Kim MY; Ji SY; Lee H; Kim GY; Kwon CY; Leem SH; Hong SH; Cheong J; Choi YH
    Arch Biochem Biophys; 2021 Jan; 697():108688. PubMed ID: 33227289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells.
    He W; Ye X; Huang X; Lel W; You L; Wang L; Chen X; Qian W
    Int J Oncol; 2016 Apr; 48(4):1710-20. PubMed ID: 26892093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
    Rui YN; Xu Z; Chen Z; Zhang S
    Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-thermal plasma induces a stress response in mesothelioma cells resulting in increased endocytosis, lysosome biogenesis and autophagy.
    Shi L; Ito F; Wang Y; Okazaki Y; Tanaka H; Mizuno M; Hori M; Hirayama T; Nagasawa H; Richardson DR; Toyokuni S
    Free Radic Biol Med; 2017 Jul; 108():904-917. PubMed ID: 28465262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF126 Quenches RNF168 Function in the DNA Damage Response.
    Zhang L; Wang Z; Shi R; Zhu X; Zhou J; Peng B; Xu X
    Genomics Proteomics Bioinformatics; 2018 Dec; 16(6):428-438. PubMed ID: 30529286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.
    Yoshimi A; Goyama S; Watanabe-Okochi N; Yoshiki Y; Nannya Y; Nitta E; Arai S; Sato T; Shimabe M; Nakagawa M; Imai Y; Kitamura T; Kurokawa M
    Blood; 2011 Mar; 117(13):3617-28. PubMed ID: 21289308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol enhances BCR-ABL TKIs' inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression.
    Tan Z; Peng A; Xu J; Ouyang M
    BMC Anesthesiol; 2017 Sep; 17(1):132. PubMed ID: 28962554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
    Koo J; Wu X; Mao Z; Khuri FR; Sun SY
    J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
    Li J; Xue L; Hao H; Han Y; Yang J; Luo J
    Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo.
    Su Y; Li X; Ma J; Zhao J; Liu S; Wang G; Edwards H; Taub JW; Lin H; Ge Y
    Biochem Pharmacol; 2018 Feb; 148():13-26. PubMed ID: 29208365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.
    Smith CJ; Berry DM; McGlade CJ
    J Cell Sci; 2013 Mar; 126(Pt 6):1366-80. PubMed ID: 23418353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock factor 4 regulates lysosome activity by modulating the αB-crystallin-ATP6V1A-mTOR complex in ocular lens.
    Cui X; Feng R; Wang J; Du C; Pi X; Chen D; Li J; Li H; Zhang J; Zhang J; Mu H; Zhang F; Liu M; Hu Y
    Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129496. PubMed ID: 31786107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ligase SCF
    Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
    Life Sci; 2020 Sep; 257():118041. PubMed ID: 32622945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic acid targets acute myeloid leukemia via Akt/mTOR-dependent mitochondrial respiration inhibition.
    Gu R; Zhang M; Meng H; Xu D; Xie Y
    Biomed Pharmacother; 2018 Sep; 105():491-497. PubMed ID: 29883944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.